Guan C, Chen R, Wang Y (2025) Inflammatory markers mediate association of AIP with kidney failure risk: data from national health and nutrition examination survey (NHANES) 2005-2018. Ren Fail 47(1):2486565. https://doi.org/10.1080/0886022x.2025.2486565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin DC, Yun SR, Lee SW, Han SW, Kim W, Park J et al (1985) Lessons from 30 years’ data of Korean end-stage renal disease registry, 1985-2015. Kidney Res Clin Pract 34(3):132–139. https://doi.org/10.1016/j.krcp.2015.08.004

Article  Google Scholar 

Van Loon E, Bernards J, Van Craenenbroeck AH, Naesens M (2020) The causes of kidney allograft failure: more than alloimmunity. A viewpoint article. Transplantation 104(2):e46–e56. https://doi.org/10.1097/tp.0000000000003012

Article  PubMed  Google Scholar 

Poggio ED, Augustine JJ, Arrigain S, Brennan DC, Schold JD (2021) Long-term kidney transplant graft survival-making progress when most needed. Am J Transplant 21(8):2824–2832. https://doi.org/10.1111/ajt.16463

Article  PubMed  Google Scholar 

Hu Y, Yang L, Sun Z, Zhang X, Zhu X, Li J et al (2025) The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study. Lipids Health Dis 24(1):91. https://doi.org/10.1186/s12944-025-02510-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karcz M, Kusztal M, Boratyńska M, Klinger M (2018) Very long-term survival of the transplanted kidney-characteristics of recipients. Transplant Proc 50(6):1730–1732. https://doi.org/10.1016/j.transproceed.2018.02.114

Article  CAS  PubMed  Google Scholar 

Lamb KE, Lodhi S, Meier-Kriesche HU (2011) Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 11(3):450–462. https://doi.org/10.1111/j.1600-6143.2010.03283.x

Article  CAS  PubMed  Google Scholar 

Gill JS, Rose C, Pereira BJ, Tonelli M (2007) The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 71(5):442–447. https://doi.org/10.1038/sj.ki.5002072

Article  CAS  PubMed  Google Scholar 

Mikolasevic I, Žutelija M, Mavrinac V, Orlic L (2017) Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis 10:35–45. https://doi.org/10.2147/ijnrd.S101808

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J (2025) Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with cardiovascular-Kidney-Metabolic syndrome. Cardiovasc Diabetol 24(1):183. https://doi.org/10.1186/s12933-025-02742-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pham Thai D, Nguyen Thi Thu H, Nguyen Tri T, Tran Dac T, Nguyen Trung K, Nguyen Huu D et al (2025) High atherogenic index of plasma associated with delayed graft function in living donor renal transplant recipients: a single-center study in Vietnam. J Clin Lab Anal 39(2):e25142. https://doi.org/10.1002/jcla.25142

Article  PubMed  Google Scholar 

Fellström B, Jardine AG, Soveri I, Cole E, Neumayer HH, Maes B et al (2005) Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation. Am J Transplant 5(8):1986–1991. https://doi.org/10.1111/j.1600-6143.2005.00983.x

Article  PubMed  Google Scholar 

El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM et al (2009) Identifying specific causes of kidney allograft loss. Am J Transplant 9(3):527–535. https://doi.org/10.1111/j.1600-6143.2008.02519.x

Article  CAS  PubMed  Google Scholar 

Yin J, Li M, Yu L, Hu F, Yu Y, Hu L et al (2021) The relationship between the atherogenic index of plasma and arterial stiffness in essential hypertensive patients from China: a cross-sectional study. BMC Cardiovasc Disord 21(1):245. https://doi.org/10.1186/s12872-021-02049-8

Article  PubMed  PubMed Central  Google Scholar 

Zhu L, Lv T, Song S, Tan Y, She Y, Zhou X et al (2025) Association of atherogenic index of plasma with kidney dysfunction in diabetic individuals: findings from two national population-based studies. BMC Endocr Disord 25(1):105. https://doi.org/10.1186/s12902-025-01925-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clayton PA, Lim WH, Wong G, Chadban SJ (2016) Relationship between eGFR decline and hard outcomes after kidney transplants. J Am Soc Nephrol 27(11):3440–3446. https://doi.org/10.1681/asn.2015050524

Article  PubMed  PubMed Central  Google Scholar 

Li X, Wang L, Zhou H, Xu H (2024) Association between triglyceride-glucose index and chronic kidney disease: results from NHANES 1999-2020. Int Urol Nephrol 56(11):3605–3616. https://doi.org/10.1007/s11255-024-04103-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Wan H, Luo Y, Chen L (2024) Association of triglyceride-glucose-body mass index with all-cause and cardiovascular mortality among individuals with chronic kidney disease. Sci Rep 14(1):20593. https://doi.org/10.1038/s41598-024-71579-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Liu Y, Wu S, Long S, Feng L, Lu W et al (2024) Comparison of TyG and newly TyG related indicators for chronic kidney diseases estimation in a Chinese population. Diabetes Metab Syndr Obes 17:3063–3075. https://doi.org/10.2147/dmso.S469260

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei S, Wu T, You Y, Liu F, Hou Q, Mo C et al (2024) Correlation between the triglyceride-glucose index and chronic kidney disease among adults with metabolic-associated fatty liver disease: fourteen-year follow-up. Front Endocrinol (Lausanne) 15:1400448. https://doi.org/10.3389/fendo.2024.1400448

Article  PubMed  PubMed Central  Google Scholar 

You FF, Gao J, Gao YN, Li ZH, Shen D, Zhong WF et al (2024) Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population‑based cohort study. Cardiovasc Diabetol 23(1):276. https://doi.org/10.1186/s12933-024-02370-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Li W, Zhou H, Zeng H, Jiang J, Wang Q et al (2025) Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0-3: insights from CHARLS. Cardiovasc Diabetol 24(1):168. https://doi.org/10.1186/s12933-025-02732-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y et al (2025) Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol 24(1):254. https://doi.org/10.1186/s12933-025-02784-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J et al (2025) Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol 24(1):22. https://doi.org/10.1186/s12933-025-02589-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Liang Y, Li J, Li X, Yu M, Cui W (2025) Correlation between atherogenic index of plasma and cardiovascular disease risk across cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol 24(1):40. https://doi.org/10.1186/s12933-025-02593-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Song Y, Lu Y, Liu T, Yin P (2025) Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study. Front Endocrinol (Lausanne) 16:1517658. https://doi.org/10.3389/fendo.2025.1517658